Mirum Pharmaceuticals Inc
MIRM
$89.70+0.38%
End of day · as of Sep 27, 2026, 1:00 PM ET
Mkt cap
$6.22B
EV/Sales
11.4
P/E ratio
N/A
FY2025 Revenue
$521.31M
EPS (TTM)
$-14.08
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-4.48%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported MIRM revenue for 2025-12-31 was $521.3M. Net income was -$23.4M. Revenue was up 54.7% from 2024-12-31 to 2025-12-31. MIRM currently screens at market cap $6.22B.
Use this MIRM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MIRM income, balance, and cash tables.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company in the Healthcare sector.
Latest cached Mirum Pharmaceuticals Inc (MIRM) revenue for Dec 31, 2025 was $521.3M. Net income was -$23.4M. Statements: https://lician.com/financials/mirm
Mirum Pharmaceuticals Inc (MIRM) market capitalization is $6.22B on the latest cached snapshot.
Mirum Pharmaceuticals Inc (MIRM) cached previous close $89.36; day range $88.28 – $90.81; volume 761,935. Session quote: https://lician.com/quote/mirm
Mirum Pharmaceuticals Inc (MIRM) latest cached earnings event is "MIRM earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MIRM filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/mirm